The Healthcare Supply Chain Association has announced its support for a new legislation aimed at creating a more competitive generic drug marketplace. HSCA confirmed its support for the "Increasing Competition in Pharmaceuticals Act" in a letter to the chair and ranking member of the Senate Special Committee on Aging.
The legislation is sponsored by Senators Susan Collins (R-Maine) and Claire McCaskill (D-Mo.).
"The 'Increasing Competition in Pharmaceuticals Act' is an important step toward fostering a more competitive generic drug marketplace and ensuring patient access to affordable medications," said HSCA President and CEO Todd Ebert. "HSCA applauds Senators Collins and McCaskill for their leadership on S.2615 and we support the legislation's mandated priority review of abbreviated new drug applications for generic drugs made by just one manufacturer. Healthcare group purchasing organizations have a unique line of sight on the healthcare supply chain, and we look forward to continuing to serve as a resource to the Senate Special Committee on Aging as they work to advance S.2615."